Randomized, Open Label, Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE Therapy in Hepatocellular Carcinoma
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results of an interim analysis (n=40, Jan 2017), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 15 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 24 Jul 2015 New trial record